IX. Proposed Addition to Appendix D of the NIH Guidelines 
Regarding Human Gene Transfer Protocol Entitled A Phase II 
Trial of High-Dose Carboplatin and Etoposide with Autologous 
Marrow Support for Treatment of Relapse/Refractory 
Neuroblastoma Without Apparent Bone Marrow Involvement: Use 
of Marker Gene to Investigate the Biology of Marrow 
Reconstitution and the Mechanism of Relapse (Dr . Brenner 
Dr. Erickson 37 
X. Future Meeting Dates 
Dr. Walters 41 
XI. Adjournment 
Dr. Walters 42 
[370] 
Recombinant DNA Research, Volume 14 
